Compare Humana Inc (HUM) vs Marvell Technology Inc (MRVL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Marvell Technology Inc — how do they compare? Humana Inc trades at $444.74 (market cap $46.49B), while Marvell Technology Inc trades at $278.81 (market cap $246.84B). The key difference: Marvell Technology Inc is far larger — about 5.3× Humana Inc's market cap, and Humana Inc pays the higher dividend (0.91%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Marvell Technology Inc for 42 Days on average.
| HUM | MRVL | |
|---|---|---|
Market Cap | $46.49B | $246.84B |
Volume | 2,567,704 | 29,003,830 |
Sector | Health | Technology |
52-Week High | $409.85 | $316.43 |
52-Week Low | $163.67 | $73.73 |
Typical Hold Time | 53 Days | 42 Days |
Enterprise Value | $53.84B | $248.19B |
Dividend Yield | 0.91% | 0.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $396.51, down 1.92% on the day, with strong technical momentum showing bullish moving averages and key support at $391. The company demonstrates consistent revenue growth reaching $129.7B in 2025, though net margins have compressed to 0.88%. Recent quarterly earnings have exceeded expectations, with Q2 2026 EPS of $7.61 beating estimates of $7.27. Analyst sentiment remains positive with a $432.63 consensus price target representing 9% upside potential from current levels.
The investment case centers on Humana's dominant Medicare Advantage position and consistent revenue growth, though margin pressure and regulatory scrutiny present headwinds. With 43% of analysts maintaining buy ratings and institutional accumulation continuing, the stock offers exposure to healthcare demographics but requires monitoring of enrollment trends and cost management execution.
Marvell Technology (MRVL) trades at $284.68, down 0.81% on the day, amid strong bullish technical signals and robust analyst optimism. The stock has delivered consecutive earnings beats, with Q2 2026 EPS of $0.94 exceeding expectations, and is supported by a consensus price target of $327.86. Revenue growth is accelerating, driven by data center demand and custom AI chip deals, though valuation multiples remain elevated with a P/E of 94.26.
The outlook is positive, fueled by AI infrastructure investments and raised fiscal 2028 revenue guidance to $18 billion. Key risks include high valuation sensitivity, competitive pressures, and execution challenges in scaling custom chip production. Analyst consensus is strongly bullish, with 84% buy ratings, but investors should weigh growth prospects against premium pricing and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Marvell Technology Inc
Marvell Technology is a leading fabless chipmaker focused on networking and storage applications. Marvell serves the data center, carrier, enterprise, automotive, and consumer end markets with processors, optical interconnections, application-specific integrated circuits (ASICs), and merchant silicon for Ethernet applications. The firm is an active acquirer, with five large acquisitions since 2017 helping it pivot out of legacy consumer applications to focus on the cloud and 5G markets.
Read more on MRVL →
